null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-000692-14-FI

Enrollment

Unknown

Registered

2011-10-26

Start date

2011-11-03

Completion date

Unknown

Last updated

2016-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.0 Level: LLT Classification code 10067624 Term: Knee arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders MedDRA version: 14.0 Level: LLT Classification code 10036284 Term: Post-operative hip pain System Organ Class: 10022117 - Injury, poisoning and procedural complications MedDRA version: 14.0 Level: LLT Classification code 10023479 Term: Knee total replacement System Organ Class: 10042613 - Surgical and medical procedures MedDRA version

Interventions

Trade Name: Norspan 5mikrog/h laastari Norspan 10 mikrog/h laastari Product Name: Norspan Product Code: N02AE01 Pharmaceutical Form: Cutaneous patch INN or Proposed INN: BUPRENORPHINE CAS Number: 524

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 100

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactHannu Kokki

Kuopio University Hospital

358017173311

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026